申请人:GLAXOSMITHKLINE IP DEV LTD
公开号:WO2019034701A1
公开(公告)日:2019-02-21
The invention relates to compounds of Formula (I) and their use in therapy, for example in the treatment of mycobacterial infections or in the treatment of diseases caused by mycobacterium, such as tuberculosis.
该发明涉及式(I)的化合物及其在治疗中的应用,例如在治疗分枝杆菌感染或治疗由分枝杆菌引起的疾病,如结核病。